This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

The firm is developing the immunotherapy IMNN-001 for treating ovarian cancer and assessing its efficacy in patients with homologous recombination deficiency.

A recent study published in Engineering has shed light on the transmission and epidemiological trends of ...